The impact of preexisting comorbidities on receipt of cancer therapy among women with Stage I-III breast cancer in the Detroit Research on Cancer Survivors cohort.

Sreejata RaychaudhuriJaclyn M KykoJulie J RuterbuschStephanie S PandolfiJennifer L Beebe-DimmerAnn G SchwartzMichael S Simon

Published in: Cancer medicine (2023)

History of prior co-morbidities has a potentially detrimental influence on receipt of recommended cancer-directed treatment among women with Stage I-III breast cancer.

Keyphrases

cancer therapy
childhood cancer
papillary thyroid
drug delivery
squamous cell
breast cancer risk